1946 Antarctica PBM Mariner crash

Prescription Costs Projected to Rise to Nearly 10% According to 2024 Segal Health Plan Cost Trend Survey

Retrieved on: 
Thursday, September 14, 2023
General Health, Consulting, Health, Professional Services, Other Professional Services, American Diabetes Association, Diabetes, PPO, MCO, POS, TPA, Psoriasis, Plasma protein binding, Medicare, 1946 Antarctica PBM Mariner crash, Autoimmune disease, Growth, Consultant, Social media, Health insurance

The projected annual cost trend for outpatient prescription drugs is expected to approach 10 percent, coming after three years of actual trend exceeding projections, according to new data from the 2024 Segal Health Plan Cost Trend Survey , released by leading benefits and HR consulting firm Segal .

Key Points: 
  • The projected annual cost trend for outpatient prescription drugs is expected to approach 10 percent, coming after three years of actual trend exceeding projections, according to new data from the 2024 Segal Health Plan Cost Trend Survey , released by leading benefits and HR consulting firm Segal .
  • The projected rise is to be driven by factors including prescription drug inflation, which continues to be the primary driver for inpatient hospital, physician and overall prescription medication trends.
  • Respondents shared their trend forecasts for medical, prescription drug, dental and vision coverage and actual health cost trends based on their group health plan experience.
  • In addition, Segal’s annual survey report provides insight on how plan sponsors can address growing health costs.

TheracosBio and SmithRx Collaborate to Offer Newly Approved Diabetes Drug Brenzavvy™ (bexagliflozin) to Members with Type 2 Diabetes

Retrieved on: 
Thursday, August 17, 2023
Software, Biotechnology, Pharmaceutical, Health, Diabetes, Data Management, Health Technology, Technology, Diabetic neuropathy, Type 2 diabetes, Tenderness, Glycosuria, Dialysis, Gangrene, Pain, Urinary tract infection, 1946 Antarctica PBM Mariner crash, Incidence, Patient, Risk, PBM, Insulin, Ulcer, Pancreatitis, Diet, Cardiovascular disease, Urination, Vomiting, Cost Plus Drugs, Hypoglycemia, FDA, Death, Exercise, World Market (store), Chronic kidney disease, Amputation, Creatinine, Hypotension, Dehydration, Metabolic acidosis, Fever, CVD, Osteomyelitis, History, Abdominal pain, Ischemia, Erythema, Swelling, Type, Moyamoya disease, Knee, Infection, Pyelonephritis, Elijah Cummings Lower Drug Costs Now Act, Partnership, Hospital, Necrotizing fasciitis, Diabetic ketoacidosis, Pharmacy, Perineum, SGLT2, Ketoacidosis, Acute kidney injury, Frenz, Nausea, Female, Pharmaceutical industry, Dietary supplement, Medical imaging, Meat

Working with TheracosBio and Cost Plus Drugs, SmithRx now provides BRENZAVVY as an option following its launch in July 2023.

Key Points: 
  • Working with TheracosBio and Cost Plus Drugs, SmithRx now provides BRENZAVVY as an option following its launch in July 2023.
  • BRENZAVVY is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
  • Diabetes is the most expensive chronic condition in the U.S. and accounts for 1 of every 4 dollars spent on healthcare.
  • In patients with type 1 diabetes mellitus, BRENZAVVY significantly increases the risk of diabetic ketoacidosis, a life-threatening event, beyond background rate.

Codoxo CEO and Founder Dr. Musheer Ahmed Honored as 40 Under 40 Georgia Tech Alumni

Retrieved on: 
Thursday, July 20, 2023
1946 Antarctica PBM Mariner crash, Georgia Tech, Fraud, Georgia Tech Alumni Association, Medical device, AI

DULUTH, Ga., July 20, 2023 /PRNewswire-PRWeb/ -- Codoxo, a trusted provider of AI solutions for healthcare payers, agencies, and pharmacy benefits managers (PBMs), today announced that CEO and Founder Dr. Musheer Ahmed has been recognized as a 40 Under 40 Georgia Tech Alumni Class of 2023.

Key Points: 
  • Dr. Ahmed was recognized for his contributions, both personally and professionally, earning a top spot among global Georgia Tech peers
    DULUTH, Ga., July 20, 2023 /PRNewswire-PRWeb/ -- Codoxo, a trusted provider of AI solutions for healthcare payers, agencies, and pharmacy benefits managers (PBMs), today announced that CEO and Founder Dr. Musheer Ahmed has been recognized as a 40 Under 40 Georgia Tech Alumni Class of 2023.
  • Dr. Ahmed was selected among an elite group of Georgia Tech peers who are highly successful innovators, researchers, and trendsetters.
  • "This recognition is especially meaningful because I developed Codoxo's patented AI technology as part of my doctoral dissertation at Georgia Tech," said Dr. Ahmed.
  • The Georgia Tech Alumni Association will recognize Dr. Ahmed during an award ceremony in November, with additional details in the fall alumni magazine and their website.

National Health Insurer Scorecard Highlights Serious Medication Access Barriers Among People Living with Autoimmune Diseases

Retrieved on: 
Thursday, January 26, 2023
Professional Services, Health, Insurance, Health Insurance, Managed Care, General Health, Pharmaceutical, Joint, Pharmacy, Public policy, Ulcerative colitis, Human, Medicare Advantage, Rheumatoid arthritis, Driskell, Anthem, Member of Congress, 1946 Antarctica PBM Mariner crash, AARP, Prescription, Medicare, Federal Trade Commission, Patient, Aetna, Cigna, Congress, Lupus nephritis, Multiple sclerosis, Psoriasis, Health insurance, Health care, Humana

The scorecard examines three common types of medication access barriers that patients often encounter with their insurer: restrictive formulary placement, step therapy, and prior authorization.

Key Points: 
  • The scorecard examines three common types of medication access barriers that patients often encounter with their insurer: restrictive formulary placement, step therapy, and prior authorization.
  • “Unfortunately, many patients – regardless of insurance type – face significant barriers to accessing the medicines they need to keep their conditions under control.
  • This reinforces how health plans give little deference to patient-physician decision-making in selecting medicines for autoimmune diseases, even for those administered in a doctor’s office.
  • The autoimmune diseases covered by this scorecard collectively affect an estimated 15.9 million Americans.

Global Healthy Living Foundation Launches Free Tool Demonstrating How State Laws Protecting Patient Assistance Programs Impact Health Insurance Premiums

Retrieved on: 
Tuesday, November 29, 2022
Technology, Insurance, Professional Services, Public Policy, Government, Health Insurance, Software, State, Local, Pharmaceutical, Health, Data Management, COVID-19, Affordable Care Act, Injury, Legislation, Conditional sentence, MS, Osteoporosis, Care Act 2014, OOP, Insurance, PBM, Social media, Caregiver, Policy, Patient, Cardiovascular disease, Education, Arthritis, HIX, Robert Wood Johnson Foundation, Platinum, Gold, Doctor of Pharmacy, Pharmacy, Health insurance marketplace, Rest, Family, Migraine, Quality of life, Psoriasis, ACA, ANOVA, 1946 Antarctica PBM Mariner crash, Vaccine, Silver, Inflammatory bowel disease, Health insurance

The Global Healthy Living Foundation (GHLF) today launched a free, interactive tool that will provide legislators, policy makers, and interested parties with objective data demonstrating how U.S. health insurance premiums have fluctuated since 2014.

Key Points: 
  • The Global Healthy Living Foundation (GHLF) today launched a free, interactive tool that will provide legislators, policy makers, and interested parties with objective data demonstrating how U.S. health insurance premiums have fluctuated since 2014.
  • Our analysis shows that the assertion made by insurance companies and PBMs that restricting accumulator and maximizer programs will cause higher health insurance premiums simply isnt true.
  • The second variable analyzed was the introduction of legislation protecting patient assistance programs by prohibiting accumulators and/or maximizers.
  • This tool will help stakeholders visualize health insurance premium changes year to year and, specifically, as related to restriction of accumulator and maximizer programs, said Louis Tharp, executive director and co-founder, Global Healthy Living Foundation.

Penstock Launches ClearFile, Names Joe Boyle President of Regulatory Solutions

Retrieved on: 
Wednesday, September 14, 2022
Sola, Affordable Care Act, Time, Risk, Boston Medical Center, QHP, Famulus, 1946 Antarctica PBM Mariner crash, Certification, CARE Act, Aetna, Solution, Hospital, Health insurance, Penstock

Joe Boyle has joined Penstock as president of regulatory solutions and will lead ClearFile.

Key Points: 
  • Joe Boyle has joined Penstock as president of regulatory solutions and will lead ClearFile.
  • Penstock is an affiliate company of Goodroot, which launches and grows companies dedicated to increasing access and affordability in healthcare.
  • "Penstock was born from a commitment to lower healthcare costs by developing unique solutions that address waste, remove errors and streamline the complex regulatory environment for health plans," says Penstock president Laura Collier.
  • Penstock is a healthcare payment integrity and reimbursement company dedicated to reducing costs for healthcare payer organizations and their members.